Prediction of phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling

CR Gibson, A Bergman, P Lu, F Kesisoglou… - Xenobiotica, 2009 - Taylor & Francis
Ten compounds from the Merck Research Laboratories pipeline were selected to evaluate
the utility of using intrinsic clearance derived from recombinantly expressed cytochromes …

[PDF][PDF] Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling

CR Gibson, A Bergman, P Lu, F Kesisoglou… - Xenobiotica, 2009 - academia.edu
Ten compounds from the Merck Research Laboratories pipeline were selected to evaluate
the utility of using intrinsic clearance derived from recombinantly expressed cytochromes …

[引用][C] Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling

CR Gibson, A Bergman, P Lu, F Kesisoglou… - Xenobiotica, 2009 - cir.nii.ac.jp
Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and
physiologically based modelling | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling.

CR Gibson, A Bergman, P Lu, F Kesisoglou… - Xenobiotica; the Fate …, 2009 - europepmc.org
1. Ten compounds from the Merck Research Laboratories pipeline were selected to
evaluate the utility of using intrinsic clearance derived from recombinantly expressed …

Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling.

CR Gibson, A Bergman, P Lu, F Kesisoglou… - …, 2009 - search.ebscohost.com
Ten compounds from the Merck Research Laboratories pipeline were selected to evaluate
the utility of using intrinsic clearance derived from recombinantly expressed cytochromes …

Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling

CR Gibson, A Bergman, P Lu… - … ; the fate of foreign …, 2009 - pubmed.ncbi.nlm.nih.gov
1. Ten compounds from the Merck Research Laboratories pipeline were selected to
evaluate the utility of using intrinsic clearance derived from recombinantly expressed …